TY - JOUR
T1 - Aging and susceptibility to drug‐induced orthostatic hypotension
AU - Tonkin, Anne
AU - Wing, Lindon
PY - 1992/9
Y1 - 1992/9
N2 - Objective: To test the hypothesis that the short‐term effect of transbuccal nitroglycerin (glyceryl trinitrate, 0.0625 to 1.5 mg) on orthostatic cardiovascular responses would predict the effect of a diuretic (5 mg bendroflumethiazide daily for 1 week), particularly in elderly subjects who may be at higher risk for orthostatic hypotension. Methods: This was a randomized crossover study. Participants were 17 elderly (age range, 63 to 84 years) and 15 younger (age range, 19 to 35 years) healthy ambulant volunteers. Interventions and measures of outcome included blood pressure (BP; in millimeters of mercury) and heart rate (HR; in beats per minute) changes with standing, which were measured before administration of medication and after each drug treatment. Results: Subjects in the elderly and younger groups had different BP and HR changes (mean percentage change) at 1 minute after standing in all three study phases (unmedicated, elderly: BP, −4%/+ 1%; HR, +12%; young: BP, +2%/+ 12%; HR, +27% p = 0.06 for BP, p < 0.01 for HR; bendroflumethiazide, elderly: BP, −9%/−3%; HR, + 17%; young: BP, + 1%/+ 11%; HR, +33% p < 0.05 for all; nitroglycerin (0.25 mg), elderly: BP, −15%/−12%; HR, +21%; young: BP, −6%/ + 7%; HR, +38%; p < 0.05 for all). The incremental orthostatic effects of the two drugs were similar in the two age groups and were positively correlated (r = 0.65, p < 0.001) in individual subjects. Conclusions: Individual susceptibility to drug‐induced orthostatic hypotension depends on a combination of the age‐related unmedicated orthostatic response and the additional drug effect, which is independent of age. The BP response to standing after administration of nitroglycerin may be useful in predicting the effect of other drugs known to influence orthostatic BP control. Clinical Pharmacology and Therapeutics (1992) 52, 277–285; doi:
AB - Objective: To test the hypothesis that the short‐term effect of transbuccal nitroglycerin (glyceryl trinitrate, 0.0625 to 1.5 mg) on orthostatic cardiovascular responses would predict the effect of a diuretic (5 mg bendroflumethiazide daily for 1 week), particularly in elderly subjects who may be at higher risk for orthostatic hypotension. Methods: This was a randomized crossover study. Participants were 17 elderly (age range, 63 to 84 years) and 15 younger (age range, 19 to 35 years) healthy ambulant volunteers. Interventions and measures of outcome included blood pressure (BP; in millimeters of mercury) and heart rate (HR; in beats per minute) changes with standing, which were measured before administration of medication and after each drug treatment. Results: Subjects in the elderly and younger groups had different BP and HR changes (mean percentage change) at 1 minute after standing in all three study phases (unmedicated, elderly: BP, −4%/+ 1%; HR, +12%; young: BP, +2%/+ 12%; HR, +27% p = 0.06 for BP, p < 0.01 for HR; bendroflumethiazide, elderly: BP, −9%/−3%; HR, + 17%; young: BP, + 1%/+ 11%; HR, +33% p < 0.05 for all; nitroglycerin (0.25 mg), elderly: BP, −15%/−12%; HR, +21%; young: BP, −6%/ + 7%; HR, +38%; p < 0.05 for all). The incremental orthostatic effects of the two drugs were similar in the two age groups and were positively correlated (r = 0.65, p < 0.001) in individual subjects. Conclusions: Individual susceptibility to drug‐induced orthostatic hypotension depends on a combination of the age‐related unmedicated orthostatic response and the additional drug effect, which is independent of age. The BP response to standing after administration of nitroglycerin may be useful in predicting the effect of other drugs known to influence orthostatic BP control. Clinical Pharmacology and Therapeutics (1992) 52, 277–285; doi:
UR - http://www.scopus.com/inward/record.url?scp=0026712472&partnerID=8YFLogxK
U2 - 10.1038/clpt.1992.142
DO - 10.1038/clpt.1992.142
M3 - Article
C2 - 1526085
AN - SCOPUS:0026712472
SN - 0009-9236
VL - 52
SP - 277
EP - 285
JO - Clinical Pharmacology & Therapeutics
JF - Clinical Pharmacology & Therapeutics
IS - 3
ER -